This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (37)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Women's Health  • Menopause  • Review  • Alert me on articles by topic

Howard M. Fillit, MD

Arch Intern Med. 2002;162:1934-1942.

Alzheimer disease (AD) is the most common form of dementia among the elderly. A higher prevalence of AD in women than in men suggests a link between gonadal hormone levels and AD. Increasing evidence supports a role for estrogen in brain regions involved in learning and memory and in the protection and regulation of cholinergic neurons, which degenerate in AD. Despite the lack of consensus, many studies indicate that hormone replacement therapy may decrease the risk for or delay the onset of AD in postmenopausal women. Recent trials have suggested that estrogen treatment may have no significant effect on the clinical course of AD in elderly women with the disease. Thus, the role of estrogen therapy seems to be confined to primary rather than secondary prevention of AD. Ongoing clinical studies may help to determine the role of estrogen in the cognitive function of postmenopausal women and in the prevention of AD.

From The Institute for the Study of Aging, Inc, New York, NY.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Investigative Models for Determining Hormone Therapy-Induced Outcomes in Brain: Evidence in Support of a Healthy Cell Bias of Estrogen Action
BRINTON
Ann. N. Y. Acad. Sci. 2005;1052:57-74.
ABSTRACT | FULL TEXT  

Estrogen and Selective Estrogen Receptor Modulators Exert Neuroprotective Effects and Stimulate the Expression of Selective Alzheimer's Disease Indicator-1, a Recently Discovered Antiapoptotic Gene, in Human Neuroblast Long-Term Cell Cultures
Benvenuti et al.
J. Clin. Endocrinol. Metab. 2005;90:1775-1782.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women
Kang et al.
Neurology 2004;63:101-107.
ABSTRACT | FULL TEXT  

Copper Perturbation in 2 Monozygotic Twins Discordant for Degree of Cognitive Impairment
Squitti et al.
Arch Neurol 2004;61:738-743.
ABSTRACT | FULL TEXT  

Aromatase Expression by Reactive Astroglia Is Neuroprotective
AZCOITIA et al.
Ann. N. Y. Acad. Sci. 2003;1007:298-305.
ABSTRACT | FULL TEXT  

Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding
Hickey et al.
Hum Reprod 2003;18:1100-1106.
ABSTRACT | FULL TEXT  

Management of Alzheimer's Disease
Grossberg and Desai
J. Gerontol. A Biol. Sci. Med. Sci. 2003;58:M331-353.
FULL TEXT